(Q38224587)

31 August 2017

1 reference

title

Tetrahydroaminoacridine (THA) in Alzheimer's disease (English)

1 reference

31 August 2017

0 references

Byrne J

1

1 reference

31 August 2017

Arie T

series ordinal

2

1 reference

31 August 2017

language of work or name

English

0 references

publication date

1 April 1989

1 reference

31 August 2017

2

1 reference

inferred from page(s)

published in

The BMJ

1 reference

31 August 2017

298

1 reference

31 August 2017

6677

1 reference

31 August 2017

845-846

1 reference

A double-blind, placebo controlled trial of high-dose lecithin in Alzheimer's disease

31 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1836130

Critical review of clinical trials in senile dementia--II.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1836130

Pharmacotherapy of cognitive deficits in Alzheimer's disease and age-associated memory impairment.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1836130

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1836130

Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1836130

Cholinomimetic treatment fails to improve memory disorders.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1836130

Use of THA in treatment of Alzheimer-like dementia: pilot study in twelve patients

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1836130

A post-mortem study of the cholinergic and GABA systems in senile dementia.

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1836130

Modest facilitation on memory in dementia with combined lecithin and anticholinerestase treatment.

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1836130

Oral physostigmine treatment of patients with Alzheimer's disease.

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1836130

Muscarinic agonist therapy of Alzheimer's disease. A clinical trial of RS-86.

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1836130

Multiple-dose arecoline infusions in Alzheimer's disease

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1836130

Hepatotoxicity of tetrahydroaminoacridine.

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1836130

Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type.

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1836130

Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1836130

Selective loss of central cholinergic neurons in Alzheimer's disease

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1836130

Alzheimer's disease. Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities.

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1836130

Neurochemical characteristics of early and late onset types of Alzheimer's disease

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1836130

Cholinergic side-effects of tetrahydroaminoacridine

31 August 2018

1 reference

12 December 2020

Cholinergic side-effects of tetrahydroaminoacridine

1 reference

12 December 2020

Tetrahydroaminoacridine and Alzheimer's disease

1 reference

12 December 2020

Oral tetrahydroaminoacridine in the treatment of senile dementia, Alzheimer's type

1 reference

12 December 2020

Treatments for Alzheimer patients--above all do no harm

1 reference

12 December 2020

Identifiers

DOI

10.1136/BMJ.298.6677.845

1 reference

31 August 2017

1 reference

31 August 2017

PubMed publication ID

2497817

1 reference